

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * fatty acid beta-oxidation (GO:0006635) | 5.35003733 |
| 2 | lysine metabolic process (GO:0006553) | 5.25660708 |
| 3 | lysine catabolic process (GO:0006554) | 5.25660708 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.21957782 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.21957782 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.13685485 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 5.13685485 |
| 8 | glyoxylate metabolic process (GO:0046487) | 4.98502167 |
| 9 | tricarboxylic acid cycle (GO:0006099) | 4.89565910 |
| 10 | regulation of sequestering of triglyceride (GO:0010889) | 4.81865289 |
| 11 | * fatty acid oxidation (GO:0019395) | 4.80504121 |
| 12 | fatty acid transmembrane transport (GO:1902001) | 4.80356806 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.78868360 |
| 14 | * fatty acid catabolic process (GO:0009062) | 4.77615876 |
| 15 | carnitine shuttle (GO:0006853) | 4.75407210 |
| 16 | 2-oxoglutarate metabolic process (GO:0006103) | 4.75162156 |
| 17 | * lipid oxidation (GO:0034440) | 4.72315352 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.69323493 |
| 19 | ATP synthesis coupled proton transport (GO:0015986) | 4.69323493 |
| 20 | short-chain fatty acid metabolic process (GO:0046459) | 4.68094607 |
| 21 | acetyl-CoA metabolic process (GO:0006084) | 4.67911502 |
| 22 | branched-chain amino acid catabolic process (GO:0009083) | 4.63255356 |
| 23 | cellular ketone body metabolic process (GO:0046950) | 4.61160089 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 4.53507767 |
| 25 | aspartate family amino acid catabolic process (GO:0009068) | 4.48497535 |
| 26 | valine metabolic process (GO:0006573) | 4.48212606 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 4.46530951 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 4.42635793 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 4.35231354 |
| 30 | * monocarboxylic acid catabolic process (GO:0072329) | 4.31769515 |
| 31 | branched-chain amino acid metabolic process (GO:0009081) | 4.30965372 |
| 32 | carnitine metabolic process (GO:0009437) | 4.22507958 |
| 33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.20470580 |
| 34 | kynurenine metabolic process (GO:0070189) | 4.16227245 |
| 35 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.08886808 |
| 36 | ethanol oxidation (GO:0006069) | 4.07946147 |
| 37 | protein complex biogenesis (GO:0070271) | 4.07772922 |
| 38 | biotin metabolic process (GO:0006768) | 3.98767141 |
| 39 | ketone body metabolic process (GO:1902224) | 3.98085860 |
| 40 | sulfur amino acid catabolic process (GO:0000098) | 3.93135826 |
| 41 | bile acid biosynthetic process (GO:0006699) | 3.86875539 |
| 42 | tricarboxylic acid metabolic process (GO:0072350) | 3.86552716 |
| 43 | carnitine transmembrane transport (GO:1902603) | 3.86476345 |
| 44 | amino-acid betaine transport (GO:0015838) | 3.86036210 |
| 45 | carnitine transport (GO:0015879) | 3.86036210 |
| 46 | cysteine metabolic process (GO:0006534) | 3.85603905 |
| 47 | tryptophan catabolic process (GO:0006569) | 3.85038367 |
| 48 | indole-containing compound catabolic process (GO:0042436) | 3.85038367 |
| 49 | indolalkylamine catabolic process (GO:0046218) | 3.85038367 |
| 50 | regulation of fatty acid oxidation (GO:0046320) | 3.84607268 |
| 51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.78137925 |
| 52 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.77583074 |
| 53 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.77275610 |
| 54 | NADH metabolic process (GO:0006734) | 3.77005235 |
| 55 | DNA deamination (GO:0045006) | 3.74736791 |
| 56 | positive regulation of fatty acid oxidation (GO:0046321) | 3.73576592 |
| 57 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.68544250 |
| 58 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.68544250 |
| 59 | NADH dehydrogenase complex assembly (GO:0010257) | 3.68544250 |
| 60 | succinate metabolic process (GO:0006105) | 3.64678391 |
| 61 | * carboxylic acid catabolic process (GO:0046395) | 3.63850544 |
| 62 | * organic acid catabolic process (GO:0016054) | 3.63850544 |
| 63 | tryptophan metabolic process (GO:0006568) | 3.62080299 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 3.56076081 |
| 65 | actin-myosin filament sliding (GO:0033275) | 3.55266849 |
| 66 | muscle filament sliding (GO:0030049) | 3.55266849 |
| 67 | thioester metabolic process (GO:0035383) | 3.51530232 |
| 68 | acyl-CoA metabolic process (GO:0006637) | 3.51530232 |
| 69 | regulation of cholesterol metabolic process (GO:0090181) | 3.49383910 |
| 70 | homocysteine metabolic process (GO:0050667) | 3.48556512 |
| 71 | regulation of mitochondrial translation (GO:0070129) | 3.48244649 |
| 72 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.48243850 |
| 73 | respiratory chain complex IV assembly (GO:0008535) | 3.47720111 |
| 74 | thioester biosynthetic process (GO:0035384) | 3.45183552 |
| 75 | acyl-CoA biosynthetic process (GO:0071616) | 3.45183552 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 3.45056927 |
| 77 | plasma lipoprotein particle clearance (GO:0034381) | 3.44941191 |
| 78 | quaternary ammonium group transport (GO:0015697) | 3.41967484 |
| 79 | acylglycerol homeostasis (GO:0055090) | 3.41695043 |
| 80 | triglyceride homeostasis (GO:0070328) | 3.41695043 |
| 81 | cytochrome complex assembly (GO:0017004) | 3.40947453 |
| 82 | serine family amino acid catabolic process (GO:0009071) | 3.40825483 |
| 83 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.36778985 |
| 84 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.35506236 |
| 85 | cytidine deamination (GO:0009972) | 3.35112459 |
| 86 | cytidine metabolic process (GO:0046087) | 3.35112459 |
| 87 | cytidine catabolic process (GO:0006216) | 3.35112459 |
| 88 | respiratory electron transport chain (GO:0022904) | 3.34281664 |
| 89 | oxaloacetate metabolic process (GO:0006107) | 3.32739111 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.31525917 |
| 91 | complement activation, alternative pathway (GO:0006957) | 3.30659387 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.30110311 |
| 93 | coenzyme catabolic process (GO:0009109) | 3.28198393 |
| 94 | ubiquinone biosynthetic process (GO:0006744) | 3.28151618 |
| 95 | bile acid metabolic process (GO:0008206) | 3.25692150 |
| 96 | sarcomere organization (GO:0045214) | 3.25335671 |
| 97 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.24822560 |
| 98 | protein carboxylation (GO:0018214) | 3.24822560 |
| 99 | electron transport chain (GO:0022900) | 3.24684031 |
| 100 | aromatic amino acid family metabolic process (GO:0009072) | 3.23568687 |
| 101 | response to mercury ion (GO:0046689) | 3.21429705 |
| 102 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.19417584 |
| 103 | high-density lipoprotein particle remodeling (GO:0034375) | 3.18241713 |
| 104 | ethanol metabolic process (GO:0006067) | 3.18115825 |
| 105 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.17806392 |
| 106 | aerobic respiration (GO:0009060) | 3.17282977 |
| 107 | urea cycle (GO:0000050) | 3.16988138 |
| 108 | urea metabolic process (GO:0019627) | 3.16988138 |
| 109 | creatine metabolic process (GO:0006600) | 3.15252426 |
| 110 | chaperone-mediated protein transport (GO:0072321) | 3.13932335 |
| 111 | ATP biosynthetic process (GO:0006754) | 3.09828112 |
| 112 | drug transmembrane transport (GO:0006855) | 3.09445252 |
| 113 | negative regulation of fibrinolysis (GO:0051918) | 3.08787961 |
| 114 | tyrosine metabolic process (GO:0006570) | 3.06302377 |
| 115 | * small molecule catabolic process (GO:0044282) | 3.05951533 |
| 116 | quinone biosynthetic process (GO:1901663) | 3.05395729 |
| 117 | nitrogen cycle metabolic process (GO:0071941) | 3.04352783 |
| 118 | oxidative phosphorylation (GO:0006119) | 3.03998566 |
| 119 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.01830732 |
| 120 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.01667006 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.00452822 |
| 122 | regulation of cofactor metabolic process (GO:0051193) | 3.00286115 |
| 123 | regulation of coenzyme metabolic process (GO:0051196) | 3.00286115 |
| 124 | regulation of protein activation cascade (GO:2000257) | 3.00010180 |
| 125 | proteasome assembly (GO:0043248) | 2.96844386 |
| 126 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.95983770 |
| 127 | heme metabolic process (GO:0042168) | 2.91970701 |
| 128 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.89882966 |
| 129 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.89882966 |
| 130 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.88237883 |
| 131 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.88237883 |
| 132 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.88237883 |
| 133 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.87412577 |
| 134 | xenobiotic catabolic process (GO:0042178) | 2.86706351 |
| 135 | aldehyde catabolic process (GO:0046185) | 2.85507877 |
| 136 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.85343306 |
| 137 | protein maturation by protein folding (GO:0022417) | 2.84036822 |
| 138 | heme biosynthetic process (GO:0006783) | 2.82865854 |
| 139 | negative regulation of B cell apoptotic process (GO:0002903) | 2.82391687 |
| 140 | hydrogen ion transmembrane transport (GO:1902600) | 2.81323943 |
| 141 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.80041548 |
| 142 | gluconeogenesis (GO:0006094) | 2.76767005 |
| 143 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.76564787 |
| 144 | daunorubicin metabolic process (GO:0044597) | 2.76358220 |
| 145 | polyketide metabolic process (GO:0030638) | 2.76358220 |
| 146 | doxorubicin metabolic process (GO:0044598) | 2.76358220 |
| 147 | ubiquinone metabolic process (GO:0006743) | 2.75344856 |
| 148 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.74755090 |
| 149 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.74755090 |
| 150 | hydrogen peroxide catabolic process (GO:0042744) | 2.74727871 |
| 151 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.74495247 |
| 152 | purine nucleotide salvage (GO:0032261) | 2.74086973 |
| 153 | metallo-sulfur cluster assembly (GO:0031163) | 2.73806914 |
| 154 | iron-sulfur cluster assembly (GO:0016226) | 2.73806914 |
| 155 | deoxyribonucleotide catabolic process (GO:0009264) | 2.73782545 |
| 156 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.72729707 |
| 157 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.71019329 |
| 158 | mitochondrial transport (GO:0006839) | 2.70678623 |
| 159 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.67839187 |
| 160 | negative regulation of ligase activity (GO:0051352) | 2.67839187 |
| 161 | monosaccharide biosynthetic process (GO:0046364) | 2.67391722 |
| 162 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.66589961 |
| 163 | quinone metabolic process (GO:1901661) | 2.65584153 |
| 164 | regulation of cellular amine metabolic process (GO:0033238) | 2.64457030 |
| 165 | regulation of cholesterol esterification (GO:0010872) | 2.64154763 |
| 166 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.63855100 |
| 167 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.62605547 |
| 168 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.62239451 |
| 169 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.62239451 |
| 170 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.62058697 |
| 171 | actin-mediated cell contraction (GO:0070252) | 2.61653759 |
| 172 | glutathione derivative metabolic process (GO:1901685) | 2.61499416 |
| 173 | glutathione derivative biosynthetic process (GO:1901687) | 2.61499416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.99020174 |
| 2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.48751617 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.24945435 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.56723686 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.99281194 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.38278206 |
| 7 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.16244592 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.09720912 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.55319991 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.50033024 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.40668893 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.34733855 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.16286713 |
| 14 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.10805107 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.68162653 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.49165418 |
| 17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.47796222 |
| 18 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.46688580 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.42789482 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.29937813 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.29559031 |
| 22 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.23254558 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.21716476 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.15955170 |
| 25 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.08585298 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.97382971 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.93948930 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92049868 |
| 29 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.87771204 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.82694582 |
| 31 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.82388360 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.77452923 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.77333201 |
| 34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72605641 |
| 35 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71947197 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71888747 |
| 37 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.70789414 |
| 38 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.69323935 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68606605 |
| 40 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.67114253 |
| 41 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.67114253 |
| 42 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.66703436 |
| 43 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.63514578 |
| 44 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59012568 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.56698629 |
| 46 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.55793649 |
| 47 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.55396740 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.53025510 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51081706 |
| 50 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.50805086 |
| 51 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.50553427 |
| 52 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.49910460 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.45613991 |
| 54 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.43682198 |
| 55 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.42798312 |
| 56 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41903559 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.41007254 |
| 58 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.40219990 |
| 59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35058623 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32824260 |
| 61 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31131998 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30465466 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30275290 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28991639 |
| 65 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.28583887 |
| 66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27357012 |
| 67 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23563352 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23408076 |
| 69 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.22052598 |
| 70 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20890122 |
| 71 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.20564496 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20508373 |
| 73 | * P68_20966046_ChIP-Seq_HELA_Human | 1.18975987 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16556702 |
| 75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15156125 |
| 76 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.14602385 |
| 77 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12925337 |
| 78 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.12507876 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.12413693 |
| 80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11137317 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09994954 |
| 82 | P300_27268052_Chip-Seq_Bcells_Human | 1.06861737 |
| 83 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.06476932 |
| 84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06081399 |
| 85 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.04213510 |
| 86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03856970 |
| 87 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.02993322 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02592492 |
| 89 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.02091981 |
| 90 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.01369316 |
| 91 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.00929993 |
| 92 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00771232 |
| 93 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.00536531 |
| 94 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98449370 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.97754574 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96486922 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96399422 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96313547 |
| 99 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.94538492 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93829704 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.93433631 |
| 102 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93066019 |
| 103 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.92294540 |
| 104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92203964 |
| 105 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.91975086 |
| 106 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91912286 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91591037 |
| 108 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91256555 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.91183764 |
| 110 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90992273 |
| 111 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.88758183 |
| 112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88662175 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87856323 |
| 114 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87542496 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86389146 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85230016 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84387458 |
| 118 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84189197 |
| 119 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.83025668 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82755264 |
| 121 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82648728 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81885935 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81885935 |
| 124 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81375390 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81059966 |
| 126 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.80779950 |
| 127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80606628 |
| 128 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79400770 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75745580 |
| 130 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.74966723 |
| 131 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74802751 |
| 132 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74354666 |
| 133 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.74146783 |
| 134 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.73979571 |
| 135 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.72783735 |
| 136 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72348501 |
| 137 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.70815941 |
| 138 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68021271 |
| 139 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.67831924 |
| 140 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67801072 |
| 141 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.67353407 |
| 142 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67183932 |
| 143 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.65701132 |
| 144 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65410184 |
| 145 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.65300325 |
| 146 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.65018230 |
| 147 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.64915274 |
| 148 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63836560 |
| 149 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.63237705 |
| 150 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.62435318 |
| 151 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.62405410 |
| 152 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.62272616 |
| 153 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.61875614 |
| 154 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.61791941 |
| 155 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61710511 |
| 156 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.61704798 |
| 157 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.61060742 |
| 158 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.60910702 |
| 159 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.60744579 |
| 160 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.60409576 |
| 161 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60328075 |
| 162 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.57980496 |
| 163 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.57757183 |
| 164 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.57214101 |
| 165 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.56415331 |
| 166 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.55252442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.03633552 |
| 2 | MP0005360_urolithiasis | 4.83911237 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 4.29747713 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.08338549 |
| 5 | MP0005365_abnormal_bile_salt | 3.89967749 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.61164377 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.46059219 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.29244503 |
| 9 | MP0003646_muscle_fatigue | 3.19217997 |
| 10 | MP0004130_abnormal_muscle_cell | 2.68878496 |
| 11 | MP0005670_abnormal_white_adipose | 2.68152949 |
| 12 | MP0005332_abnormal_amino_acid | 2.61753669 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.59970260 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.58704005 |
| 15 | MP0003195_calcinosis | 2.52722847 |
| 16 | MP0005330_cardiomyopathy | 2.41881596 |
| 17 | MP0009840_abnormal_foam_cell | 2.41198827 |
| 18 | MP0003252_abnormal_bile_duct | 2.39024668 |
| 19 | MP0004215_abnormal_myocardial_fiber | 2.31622377 |
| 20 | MP0000751_myopathy | 2.29660942 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 2.26366093 |
| 22 | MP0004036_abnormal_muscle_relaxation | 2.20052873 |
| 23 | MP0005666_abnormal_adipose_tissue | 2.18082233 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.12742922 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.98418628 |
| 26 | MP0002132_abnormal_respiratory_system | 1.97112513 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.92883906 |
| 28 | MP0000749_muscle_degeneration | 1.86668818 |
| 29 | MP0005083_abnormal_biliary_tract | 1.81148552 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.69937114 |
| 31 | MP0008775_abnormal_heart_ventricle | 1.67115998 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.66128548 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65125236 |
| 34 | MP0002972_abnormal_cardiac_muscle | 1.64318798 |
| 35 | MP0005451_abnormal_body_composition | 1.63249089 |
| 36 | MP0000609_abnormal_liver_physiology | 1.62430183 |
| 37 | MP0003186_abnormal_redox_activity | 1.62326154 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.57748294 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.56460643 |
| 40 | MP0004087_abnormal_muscle_fiber | 1.54843312 |
| 41 | MP0005385_cardiovascular_system_phenoty | 1.53879303 |
| 42 | MP0001544_abnormal_cardiovascular_syste | 1.53879303 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.49090513 |
| 44 | MP0004019_abnormal_vitamin_homeostasis | 1.47096396 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.46821793 |
| 46 | MP0002971_abnormal_brown_adipose | 1.42778249 |
| 47 | MP0004043_abnormal_pH_regulation | 1.41596084 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.41123150 |
| 49 | MP0006138_congestive_heart_failure | 1.38266965 |
| 50 | MP0005620_abnormal_muscle_contractility | 1.37797337 |
| 51 | MP0005671_abnormal_response_to | 1.30978264 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.30466947 |
| 53 | MP0010630_abnormal_cardiac_muscle | 1.30434007 |
| 54 | MP0003137_abnormal_impulse_conducting | 1.26170685 |
| 55 | MP0001764_abnormal_homeostasis | 1.24810884 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.23730906 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.21606442 |
| 58 | MP0003221_abnormal_cardiomyocyte_apopto | 1.21070182 |
| 59 | MP0002269_muscular_atrophy | 1.18086174 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.17960666 |
| 61 | MP0005535_abnormal_body_temperature | 1.16053562 |
| 62 | MP0004484_altered_response_of | 1.15333170 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.14839779 |
| 64 | MP0000750_abnormal_muscle_regeneration | 1.14380282 |
| 65 | MP0003075_altered_response_to | 1.14141948 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 1.13499180 |
| 67 | MP0000343_altered_response_to | 1.11225142 |
| 68 | MP0008872_abnormal_physiological_respon | 1.09438900 |
| 69 | MP0010368_abnormal_lymphatic_system | 1.07026799 |
| 70 | MP0004147_increased_porphyrin_level | 1.04367017 |
| 71 | MP0002106_abnormal_muscle_physiology | 1.01151526 |
| 72 | MP0000230_abnormal_systemic_arterial | 1.00971246 |
| 73 | MP0000747_muscle_weakness | 1.00883620 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.00336828 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 1.00174699 |
| 76 | MP0005334_abnormal_fat_pad | 0.99392605 |
| 77 | MP0002653_abnormal_ependyma_morphology | 0.97776934 |
| 78 | MP0001756_abnormal_urination | 0.97084919 |
| 79 | MP0005266_abnormal_metabolism | 0.94750227 |
| 80 | MP0003011_delayed_dark_adaptation | 0.93505434 |
| 81 | MP0003828_pulmonary_edema | 0.93270613 |
| 82 | MP0003786_premature_aging | 0.92247092 |
| 83 | MP0005165_increased_susceptibility_to | 0.92004041 |
| 84 | MP0005636_abnormal_mineral_homeostasis | 0.91942322 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 0.91913390 |
| 86 | MP0004085_abnormal_heartbeat | 0.90543661 |
| 87 | MP0003724_increased_susceptibility_to | 0.88860926 |
| 88 | MP0003950_abnormal_plasma_membrane | 0.88485334 |
| 89 | MP0009785_altered_susceptibility_to | 0.88267069 |
| 90 | MP0002822_catalepsy | 0.87824364 |
| 91 | MP0001873_stomach_inflammation | 0.85633190 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.85428419 |
| 93 | MP0009763_increased_sensitivity_to | 0.84861131 |
| 94 | MP0001661_extended_life_span | 0.84679264 |
| 95 | MP0003690_abnormal_glial_cell | 0.84558439 |
| 96 | MP0003718_maternal_effect | 0.83584365 |
| 97 | MP0001905_abnormal_dopamine_level | 0.82060453 |
| 98 | MP0000759_abnormal_skeletal_muscle | 0.81510644 |
| 99 | MP0005369_muscle_phenotype | 0.80261826 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.79574325 |
| 101 | MP0000598_abnormal_liver_morphology | 0.77915339 |
| 102 | MP0001727_abnormal_embryo_implantation | 0.76852916 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.76044092 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.75615574 |
| 105 | MP0008469_abnormal_protein_level | 0.75392411 |
| 106 | MP0005379_endocrine/exocrine_gland_phen | 0.75189048 |
| 107 | MP0001835_abnormal_antigen_presentation | 0.74859332 |
| 108 | MP0001881_abnormal_mammary_gland | 0.73549804 |
| 109 | MP0008058_abnormal_DNA_repair | 0.73527696 |
| 110 | MP0009115_abnormal_fat_cell | 0.73370924 |
| 111 | MP0009764_decreased_sensitivity_to | 0.72974355 |
| 112 | MP0009697_abnormal_copulation | 0.72150463 |
| 113 | MP0005025_abnormal_response_to | 0.71768066 |
| 114 | MP0005058_abnormal_lysosome_morphology | 0.70948506 |
| 115 | MP0001545_abnormal_hematopoietic_system | 0.69873611 |
| 116 | MP0005397_hematopoietic_system_phenotyp | 0.69873611 |
| 117 | MP0001853_heart_inflammation | 0.69825441 |
| 118 | MP0002127_abnormal_cardiovascular_syste | 0.68381596 |
| 119 | MP0003868_abnormal_feces_composition | 0.67860387 |
| 120 | MP0005166_decreased_susceptibility_to | 0.67032314 |
| 121 | MP0002876_abnormal_thyroid_physiology | 0.66289626 |
| 122 | MP0002136_abnormal_kidney_physiology | 0.65300059 |
| 123 | MP0002970_abnormal_white_adipose | 0.61598220 |
| 124 | MP0005647_abnormal_sex_gland | 0.61327613 |
| 125 | MP0003705_abnormal_hypodermis_morpholog | 0.60765910 |
| 126 | MP0005448_abnormal_energy_balance | 0.60652602 |
| 127 | MP0000604_amyloidosis | 0.60097108 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.59736750 |
| 129 | MP0000013_abnormal_adipose_tissue | 0.58453675 |
| 130 | MP0000003_abnormal_adipose_tissue | 0.57431132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.90345488 |
| 2 | Hypoglycemic coma (HP:0001325) | 4.71409831 |
| 3 | Hyperglycinuria (HP:0003108) | 4.47066773 |
| 4 | Ketosis (HP:0001946) | 4.33071855 |
| 5 | Hyperammonemia (HP:0001987) | 4.28971884 |
| 6 | Myoglobinuria (HP:0002913) | 4.25232506 |
| 7 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.24326987 |
| 8 | Dicarboxylic aciduria (HP:0003215) | 4.24326987 |
| 9 | Ketoacidosis (HP:0001993) | 4.16624517 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.12366479 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.09305096 |
| 12 | Abnormality of glycine metabolism (HP:0010895) | 4.09305096 |
| 13 | Nemaline bodies (HP:0003798) | 4.08674928 |
| 14 | Hepatic necrosis (HP:0002605) | 3.97117595 |
| 15 | Muscle fiber inclusion bodies (HP:0100299) | 3.95711736 |
| 16 | Xanthomatosis (HP:0000991) | 3.91542968 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.83683438 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.80079041 |
| 19 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.78048543 |
| 20 | Generalized aminoaciduria (HP:0002909) | 3.77257506 |
| 21 | Cerebral edema (HP:0002181) | 3.68748650 |
| 22 | Sudden death (HP:0001699) | 3.63949764 |
| 23 | Deep venous thrombosis (HP:0002625) | 3.63315345 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 3.60198549 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.48475610 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.48475610 |
| 27 | Ventricular tachycardia (HP:0004756) | 3.47703273 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.46917506 |
| 29 | Hyperglycinemia (HP:0002154) | 3.39954371 |
| 30 | Acute encephalopathy (HP:0006846) | 3.37622973 |
| 31 | Increased muscle lipid content (HP:0009058) | 3.30236459 |
| 32 | Exercise-induced myalgia (HP:0003738) | 3.29173407 |
| 33 | Exercise intolerance (HP:0003546) | 3.24554588 |
| 34 | Palpitations (HP:0001962) | 3.13137060 |
| 35 | Hepatocellular necrosis (HP:0001404) | 3.12638504 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.10484542 |
| 37 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.08915930 |
| 38 | Lethargy (HP:0001254) | 3.08350197 |
| 39 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.02899942 |
| 40 | Metabolic acidosis (HP:0001942) | 3.00766740 |
| 41 | Calf muscle hypertrophy (HP:0008981) | 3.00123764 |
| 42 | Prolonged partial thromboplastin time (HP:0003645) | 2.97944991 |
| 43 | Acute necrotizing encephalopathy (HP:0006965) | 2.97660029 |
| 44 | Cerebral palsy (HP:0100021) | 2.94873087 |
| 45 | Proximal tubulopathy (HP:0000114) | 2.93564903 |
| 46 | Exercise-induced muscle cramps (HP:0003710) | 2.90670648 |
| 47 | Lipoatrophy (HP:0100578) | 2.90234343 |
| 48 | Hypobetalipoproteinemia (HP:0003563) | 2.90130217 |
| 49 | Right ventricular cardiomyopathy (HP:0011663) | 2.87828284 |
| 50 | Hypolipoproteinemia (HP:0010981) | 2.87014192 |
| 51 | Increased serum lactate (HP:0002151) | 2.86714788 |
| 52 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.82278096 |
| 53 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.81589614 |
| 54 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.81077652 |
| 55 | Nausea (HP:0002018) | 2.76189868 |
| 56 | Myopathic facies (HP:0002058) | 2.75974757 |
| 57 | Muscle fiber splitting (HP:0003555) | 2.75847171 |
| 58 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.73039253 |
| 59 | Vomiting (HP:0002013) | 2.71352385 |
| 60 | Complement deficiency (HP:0004431) | 2.69372247 |
| 61 | Increased serum pyruvate (HP:0003542) | 2.68746060 |
| 62 | Abnormality of glycolysis (HP:0004366) | 2.68746060 |
| 63 | Dilated cardiomyopathy (HP:0001644) | 2.68264571 |
| 64 | Lactic acidosis (HP:0003128) | 2.66805222 |
| 65 | Renal Fanconi syndrome (HP:0001994) | 2.65287113 |
| 66 | Abnormality of serum amino acid levels (HP:0003112) | 2.64018744 |
| 67 | Atrial fibrillation (HP:0005110) | 2.63650588 |
| 68 | Increased hepatocellular lipid droplets (HP:0006565) | 2.63532592 |
| 69 | Mitochondrial inheritance (HP:0001427) | 2.60023613 |
| 70 | Increased intramyocellular lipid droplets (HP:0012240) | 2.59148371 |
| 71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.54969389 |
| 72 | Epidermoid cyst (HP:0200040) | 2.53953394 |
| 73 | Hyporeflexia of lower limbs (HP:0002600) | 2.53606731 |
| 74 | Increased CSF lactate (HP:0002490) | 2.53493312 |
| 75 | Renal cortical cysts (HP:0000803) | 2.51544263 |
| 76 | Glycosuria (HP:0003076) | 2.51460385 |
| 77 | Abnormality of urine glucose concentration (HP:0011016) | 2.51460385 |
| 78 | Type I transferrin isoform profile (HP:0003642) | 2.50512077 |
| 79 | Progressive macrocephaly (HP:0004481) | 2.47077236 |
| 80 | EMG: myopathic abnormalities (HP:0003458) | 2.42932067 |
| 81 | Primary atrial arrhythmia (HP:0001692) | 2.38084556 |
| 82 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.37670802 |
| 83 | Delayed CNS myelination (HP:0002188) | 2.36884349 |
| 84 | Lipid accumulation in hepatocytes (HP:0006561) | 2.36450507 |
| 85 | Abnormality of methionine metabolism (HP:0010901) | 2.33878103 |
| 86 | Joint hemorrhage (HP:0005261) | 2.33020663 |
| 87 | 3-Methylglutaconic aciduria (HP:0003535) | 2.32735416 |
| 88 | Abnormality of purine metabolism (HP:0004352) | 2.32158616 |
| 89 | Gout (HP:0001997) | 2.31446004 |
| 90 | Supraventricular tachycardia (HP:0004755) | 2.30981981 |
| 91 | Testicular atrophy (HP:0000029) | 2.30230188 |
| 92 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.28904642 |
| 93 | Neck muscle weakness (HP:0000467) | 2.27962826 |
| 94 | Atrioventricular block (HP:0001678) | 2.26410013 |
| 95 | Supraventricular arrhythmia (HP:0005115) | 2.25772151 |
| 96 | Syncope (HP:0001279) | 2.25519603 |
| 97 | Conjunctival hamartoma (HP:0100780) | 2.25285474 |
| 98 | Methylmalonic aciduria (HP:0012120) | 2.23380982 |
| 99 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.22680337 |
| 100 | CNS demyelination (HP:0007305) | 2.22618989 |
| 101 | Abnormality of the calf musculature (HP:0001430) | 2.21462537 |
| 102 | Asymmetric septal hypertrophy (HP:0001670) | 2.20398751 |
| 103 | Emotional lability (HP:0000712) | 2.19239076 |
| 104 | Respiratory failure (HP:0002878) | 2.19199834 |
| 105 | Hyperbilirubinemia (HP:0002904) | 2.16623246 |
| 106 | Petechiae (HP:0000967) | 2.15216251 |
| 107 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.13823538 |
| 108 | Abnormality of the common coagulation pathway (HP:0010990) | 2.13293085 |
| 109 | Skin nodule (HP:0200036) | 2.11611756 |
| 110 | Cholelithiasis (HP:0001081) | 2.11350645 |
| 111 | Cerebral hemorrhage (HP:0001342) | 2.09020354 |
| 112 | Heart block (HP:0012722) | 2.07156444 |
| 113 | Abnormal gallbladder physiology (HP:0012438) | 2.06220063 |
| 114 | Cholecystitis (HP:0001082) | 2.06220063 |
| 115 | Abnormal gallbladder morphology (HP:0012437) | 2.06025931 |
| 116 | Increased purine levels (HP:0004368) | 2.05289885 |
| 117 | Hyperuricemia (HP:0002149) | 2.05289885 |
| 118 | Microvesicular hepatic steatosis (HP:0001414) | 2.05001057 |
| 119 | Hypercholesterolemia (HP:0003124) | 2.04625518 |
| 120 | Fat malabsorption (HP:0002630) | 2.04585055 |
| 121 | Reduced antithrombin III activity (HP:0001976) | 2.03830636 |
| 122 | Opisthotonus (HP:0002179) | 2.03461198 |
| 123 | Type 1 muscle fiber predominance (HP:0003803) | 2.03353124 |
| 124 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.01228164 |
| 125 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.01228164 |
| 126 | Abnormal protein glycosylation (HP:0012346) | 2.01228164 |
| 127 | Abnormal glycosylation (HP:0012345) | 2.01228164 |
| 128 | Abnormality of nucleobase metabolism (HP:0010932) | 2.00959929 |
| 129 | Distal lower limb muscle weakness (HP:0009053) | 2.00885228 |
| 130 | Progressive muscle weakness (HP:0003323) | 2.00063251 |
| 131 | Ragged-red muscle fibers (HP:0003200) | 1.97478002 |
| 132 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.96204996 |
| 133 | Muscle stiffness (HP:0003552) | 1.95606372 |
| 134 | Abnormal pupillary function (HP:0007686) | 1.95338641 |
| 135 | Abnormality of the intrinsic pathway (HP:0010989) | 1.94581889 |
| 136 | Increased connective tissue (HP:0009025) | 1.93409005 |
| 137 | Optic disc pallor (HP:0000543) | 1.89812492 |
| 138 | Distal arthrogryposis (HP:0005684) | 1.86661726 |
| 139 | Muscle fiber atrophy (HP:0100295) | 1.86587031 |
| 140 | Type 2 muscle fiber atrophy (HP:0003554) | 1.86215145 |
| 141 | Rimmed vacuoles (HP:0003805) | 1.85426709 |
| 142 | Aplastic anemia (HP:0001915) | 1.85309750 |
| 143 | Agammaglobulinemia (HP:0004432) | 1.84831751 |
| 144 | Paralysis (HP:0003470) | 1.84302783 |
| 145 | Systemic lupus erythematosus (HP:0002725) | 1.81756687 |
| 146 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.81500454 |
| 147 | Hyperalaninemia (HP:0003348) | 1.81500454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.18427349 |
| 2 | VRK2 | 5.68064193 |
| 3 | TTN | 3.70923230 |
| 4 | TESK2 | 3.52137531 |
| 5 | PDK4 | 3.47751563 |
| 6 | PDK3 | 3.47751563 |
| 7 | MYLK | 3.17469604 |
| 8 | LMTK2 | 2.85560567 |
| 9 | TRIB3 | 2.66367990 |
| 10 | TESK1 | 2.50039210 |
| 11 | TIE1 | 2.41232375 |
| 12 | PHKG2 | 2.38038076 |
| 13 | PHKG1 | 2.38038076 |
| 14 | PDK2 | 2.31298795 |
| 15 | PKN2 | 2.26915597 |
| 16 | OBSCN | 2.26473827 |
| 17 | PIM2 | 2.19275474 |
| 18 | WNK4 | 2.18373831 |
| 19 | PINK1 | 2.10386653 |
| 20 | TXK | 2.07949946 |
| 21 | SIK1 | 1.98208266 |
| 22 | ERN1 | 1.88805271 |
| 23 | FGFR4 | 1.85208653 |
| 24 | STK39 | 1.83104770 |
| 25 | SCYL2 | 1.82204150 |
| 26 | NUAK1 | 1.80753417 |
| 27 | INSRR | 1.77211507 |
| 28 | PIK3CA | 1.76806231 |
| 29 | LIMK1 | 1.72811276 |
| 30 | MAP4K2 | 1.68328492 |
| 31 | VRK1 | 1.65188543 |
| 32 | EPHB1 | 1.64426617 |
| 33 | ARAF | 1.59289487 |
| 34 | DAPK1 | 1.59197752 |
| 35 | NME1 | 1.48328591 |
| 36 | KDR | 1.46306652 |
| 37 | STK16 | 1.46164605 |
| 38 | MUSK | 1.37288614 |
| 39 | FLT3 | 1.36225146 |
| 40 | MAP3K11 | 1.35640774 |
| 41 | MAP3K12 | 1.31508838 |
| 42 | OXSR1 | 1.29771134 |
| 43 | TNK2 | 1.26825551 |
| 44 | GRK7 | 1.24539582 |
| 45 | PRKAA2 | 1.22888724 |
| 46 | NME2 | 1.15868402 |
| 47 | MST1R | 1.15483258 |
| 48 | GRK1 | 1.12970540 |
| 49 | TGFBR2 | 1.02470519 |
| 50 | EIF2AK1 | 1.01860199 |
| 51 | PRKD1 | 1.00507625 |
| 52 | MAP2K2 | 0.97217578 |
| 53 | MAP2K3 | 0.96230256 |
| 54 | NEK9 | 0.94331266 |
| 55 | MAP3K7 | 0.91705171 |
| 56 | STK24 | 0.90639913 |
| 57 | PAK3 | 0.90510248 |
| 58 | PIK3CG | 0.89847367 |
| 59 | DMPK | 0.88945230 |
| 60 | PKN1 | 0.88529769 |
| 61 | CAMK2D | 0.87474655 |
| 62 | CAMK1D | 0.87398415 |
| 63 | SMG1 | 0.86302575 |
| 64 | BUB1 | 0.85965032 |
| 65 | MAPK12 | 0.83753296 |
| 66 | TYK2 | 0.83609480 |
| 67 | MAP3K3 | 0.83444632 |
| 68 | CSNK1G3 | 0.82772512 |
| 69 | STK38L | 0.80725869 |
| 70 | MAPK11 | 0.79017128 |
| 71 | PRKAA1 | 0.78400800 |
| 72 | NEK1 | 0.77688196 |
| 73 | ILK | 0.76333677 |
| 74 | IKBKB | 0.75589540 |
| 75 | TBK1 | 0.75557249 |
| 76 | ZAK | 0.75321692 |
| 77 | PDPK1 | 0.75068822 |
| 78 | EPHA2 | 0.74482438 |
| 79 | PRKD3 | 0.74252843 |
| 80 | MET | 0.74239978 |
| 81 | ABL2 | 0.73516893 |
| 82 | PBK | 0.71566424 |
| 83 | TAOK3 | 0.67061944 |
| 84 | IRAK3 | 0.65117952 |
| 85 | PRKCI | 0.63500000 |
| 86 | WNK3 | 0.63483145 |
| 87 | CAMK2G | 0.62211752 |
| 88 | CCNB1 | 0.61157488 |
| 89 | TRPM7 | 0.60883798 |
| 90 | JAK1 | 0.60464009 |
| 91 | PRKACG | 0.60364400 |
| 92 | FER | 0.60028488 |
| 93 | MAPKAPK5 | 0.57043187 |
| 94 | JAK2 | 0.56841810 |
| 95 | CSNK1G1 | 0.55062968 |
| 96 | SYK | 0.51156032 |
| 97 | GRK5 | 0.50419612 |
| 98 | PDK1 | 0.50385711 |
| 99 | LRRK2 | 0.50129681 |
| 100 | RPS6KA5 | 0.49831965 |
| 101 | RIPK1 | 0.49808949 |
| 102 | CSF1R | 0.49066783 |
| 103 | STK4 | 0.48895530 |
| 104 | TAOK2 | 0.48761483 |
| 105 | MAPKAPK3 | 0.48189184 |
| 106 | PTK6 | 0.47726139 |
| 107 | EIF2AK3 | 0.47442080 |
| 108 | MAPK4 | 0.47234884 |
| 109 | CSNK1A1L | 0.46214346 |
| 110 | AURKA | 0.45343887 |
| 111 | TAF1 | 0.45147023 |
| 112 | CAMK4 | 0.44676360 |
| 113 | PRKCQ | 0.44515301 |
| 114 | CSNK2A2 | 0.44305260 |
| 115 | EPHA3 | 0.43664312 |
| 116 | FGFR2 | 0.43523725 |
| 117 | TLK1 | 0.40888510 |
| 118 | GRK6 | 0.40805459 |
| 119 | ROCK1 | 0.40737939 |
| 120 | CSNK1G2 | 0.40152635 |
| 121 | CSNK2A1 | 0.40082974 |
| 122 | PRKACA | 0.39499671 |
| 123 | PRKG2 | 0.38986276 |
| 124 | RPS6KB2 | 0.38790345 |
| 125 | RPS6KA6 | 0.38128615 |
| 126 | DAPK3 | 0.37905997 |
| 127 | ERBB4 | 0.37904171 |
| 128 | IKBKE | 0.37651489 |
| 129 | RPS6KC1 | 0.37561665 |
| 130 | RPS6KL1 | 0.37561665 |
| 131 | GSK3A | 0.36585453 |
| 132 | FES | 0.35840199 |
| 133 | PRKACB | 0.35692423 |
| 134 | ITK | 0.34606931 |
| 135 | MAP2K6 | 0.34240982 |
| 136 | AKT2 | 0.33981601 |
| 137 | DYRK2 | 0.33712107 |
| 138 | ZAP70 | 0.33546809 |
| 139 | MAP4K1 | 0.32492393 |
| 140 | WNK1 | 0.32443444 |
| 141 | SGK494 | 0.30987175 |
| 142 | SGK223 | 0.30987175 |
| 143 | MAPK15 | 0.30945714 |
| 144 | ADRBK2 | 0.28878525 |
| 145 | MST4 | 0.28801708 |
| 146 | CSK | 0.28761016 |
| 147 | MAPKAPK2 | 0.28538501 |
| 148 | ATR | 0.28109668 |
| 149 | PRKCH | 0.27792405 |
| 150 | PRKCE | 0.27341538 |
| 151 | CAMK2A | 0.26441903 |
| 152 | KIT | 0.25846320 |
| 153 | MAP2K1 | 0.25178978 |
| 154 | PAK1 | 0.25163878 |
| 155 | SGK3 | 0.24077019 |
| 156 | ROCK2 | 0.23741498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.59821592 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.56560220 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.45037834 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.35477171 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.20694128 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.08101256 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.85978922 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.77749795 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.77071333 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.70485231 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.51019452 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48697963 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.39764388 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.34296188 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.27310707 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.23352780 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.17636671 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.15940099 |
| 19 | * Peroxisome_Homo sapiens_hsa04146 | 2.06820277 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 2.06136893 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.03281206 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.96042057 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.90776404 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.80879137 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64187133 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.63035799 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58604546 |
| 28 | Ribosome_Homo sapiens_hsa03010 | 1.52553615 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52275885 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49913690 |
| 31 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.47182496 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39745399 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35489369 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.34304966 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.32432003 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31729289 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.31200560 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24525677 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24398331 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23792671 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23787695 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19922403 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19258730 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16882879 |
| 45 | RNA polymerase_Homo sapiens_hsa03020 | 1.12858436 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07215981 |
| 47 | Base excision repair_Homo sapiens_hsa03410 | 1.06411545 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05207932 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05030328 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.04836707 |
| 51 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04577813 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01800480 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00471042 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99903329 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98458531 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95887909 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 0.95410176 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92387612 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91993643 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90724605 |
| 61 | DNA replication_Homo sapiens_hsa03030 | 0.88973927 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88364032 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88336289 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86801187 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86267915 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.86126366 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82651047 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.81220916 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78670407 |
| 70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.77209683 |
| 71 | Huntingtons disease_Homo sapiens_hsa05016 | 0.76931993 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.73825739 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71676830 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.69740855 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68876861 |
| 76 | Mismatch repair_Homo sapiens_hsa03430 | 0.66989227 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65390845 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65340878 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64499513 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63498310 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59553636 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58567008 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.58077355 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54714994 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53370015 |
| 86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49587712 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.49118654 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.49083931 |
| 89 | Allograft rejection_Homo sapiens_hsa05330 | 0.48702962 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48236764 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48018204 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47546584 |
| 93 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46977272 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46932685 |
| 95 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46317185 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44552177 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43407577 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41131796 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40873113 |
| 100 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.38654920 |
| 101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38606163 |
| 102 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.37695624 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37484848 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32165269 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31352156 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30865171 |
| 107 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28311788 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27249937 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26983990 |
| 110 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.26297500 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24733227 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20942047 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16769584 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14176159 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.12580757 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.11393060 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.01747941 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1551678 |
| 119 | Protein export_Homo sapiens_hsa03060 | -0.1511705 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1364428 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1347483 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1240169 |
| 123 | Lysosome_Homo sapiens_hsa04142 | -0.1196352 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | -0.1068467 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0825667 |
| 126 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0582039 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0275237 |

